The DOI matches its Crossref record.
L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological Studies
Abstract
Forty patients with acute leukemia were treated with Intravenous L-asparaginase in doses ranging from 10 to 1,000 international units/kg body weight per day for 2 to 20 days. Most had long-standing disease and had exhausted conventional therapy. The remission rate appeared to be unaffected by dose, schedule, or previous chemotherapy. There was a 66% response rate for acute lymphoblastic leukemia and an approximately 12% response rate for nonlymphocytic leukemia. Second and third remissions were obtained. Toxicity was not strictly dose related and consisted of fever, anorexia, nausea, vomiting, decreased protein synthesis, biochemical hepatic dysfunction, elevated blood ammonia, nonketotic hyperglycemia, and anaphylaxis. Although there were two deaths directly attributed to L-asparaginase, most patients tolerated the enzyme well with very little impairment of performance status. The rapid clearance of plasma enzyme and the development of passive hemagglutinating and reagin types of antibodies are correlated with the development of anaphylaxis. The relationship of plasma L-asparagine to disease status is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Use of ?-asparaginase in childhood ALL
Müller, H. (1998) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(98)00015-8 · Cited by 455
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
Narta, U. K., Kanwar, S. S., & Azmi, W. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.009 · Cited by 384
Scott Baker, K., Ness, K. K., Steinberger, J., Carter, A., Francisco, L., Burns, L. J., Sklar, C., Forman, S., Weisdorf, D., Gurney, J. G., et al. (2007) · Blood · doi:10.1182/blood-2006-05-022335 · Cited by 344
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
Egler, R. A., Ahuja, S. P., & Matloub, Y. (2016) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.184769 · Cited by 334
Comparative pharmacokinetic studies of three asparaginase preparations.
Asselin, B. L., Whitin, J. C., Coppola, D. J., Rupp, I. P., Sallan, S. E., & Cohen, H. J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1780 · Cited by 333
Metadata
- Authors
- CAPIZZI, R. L., BERTINO, J. R., SKEEL, R. T., CREASEY, W. A., ZANES, R., OLAYON, C., PETERSON, R. G., & HANDSCHUMACHER, R. E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1971-06-01
- Volume
- 74
- Issue
- 6
- Pages
- 893-901
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2016822528
- Cited by
- 180
- References
- 0
- FWCI
- 10.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological Studies. https://app.cochat.ai/papers/10.7326/0003-4819-74-6-893
- The paper
- CAPIZZI, R. L., BERTINO, J. R., SKEEL, R. T., CREASEY, W. A., ZANES, R., OLAYON, C., PETERSON, R. G., & HANDSCHUMACHER, R. E. (1971). L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological Studies. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-74-6-893
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.